Treatment and Patient Reported Outcome in Children with Hirschsprung Disease and Concomitant Congenital Heart Disease
Table 3
Summary of age and time intervals, counted in days, comparing the children with Hirschsprung disease (HD) with and without congenital heart disease (CHD) at different stages in the treatment process, presented as median number of days (range). TERPT = transanal endorectal pull-through.
HD without CHD
HD and CHD
Age at presenting symptom (days)
1.0 (0–228)
13
1.0 (0–167)
Age at first contact with pediatric surgeon (days)
40
2.5 (1–1054)
13
5.0 (1–1119)
Time from initial symptom to first counseling by pediatric surgeon (days)
2.0 (0–952)
13
4.0 (0–952)
Time from birth to first counseling by pediatric surgeon (days)
40
3.0 (1–1054)
13
5.0 (1–1098)
Age at first biopsy (days)
40
7.0 (1–1054)
13
10 (3–1138)
Age at PAD result (days)
25 (8–1172)
13
21 (7–1159)
Time between rectal biopsy and op-sign in (days)
5.0 (−2–367)
13
6.0 (0–90)
Age TERPT (days)
40
48.5 (15–1254)
13
52 (12–1279)
Time between first surgeon contact to operation reconstruction (days)
40
38.0 (12–888)
13
38.0 (9–160)
Time from diagnosis, according to PAD, until TERPT (days)
27.0 (1–418)
13
18.0 (3–120)
Days in hospital postoperatively (days)
40
4.0 (2–13)
13
4.0 (1–22)
Time from discharge until first counselling (days)
40
11.0 (2–39)
13
10.0 (4–210)
Information missing in children’s records. Mann–Whitney U test.
